🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: \- to evaluate the efficacy of Sarilumab in participant...
Status
Completed
Location
Investigational Site Number 840006
Start Date
2010-02
Trial ID
NCT01061723
This is a randomized study of the safety and tolerability of multiple doses...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT01011959
Treatments Being Tested
Primary Objective: To describe the pharmacokinetic (PK) profile of sarilum...
Status
Completed
Location
Children's Hospital Los Angeles Site Number : 8400416
Start Date
2016-09-06
Trial ID
NCT02776735
Treatments Being Tested
Primary Objective: To describe the safety and tolerability, including labo...
Status
Completed
Location
Investigational Site Number 392001
Start Date
2015-05
Trial ID
NCT02404558
Treatments Being Tested
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572
Primary Objective: To evaluate the immunogenicity of sarilumab administere...
Status
Completed
Location
Investigational Site Number 840072
Start Date
2014-06
Trial ID
NCT02121210
Treatments Being Tested
Primary Objective: To evaluate the efficacy of sarilumab at Week 16 in par...
Status
Completed
Location
Investigational Site Number 840008
Start Date
2013-10
Trial ID
NCT01900431
Treatments Being Tested
Primary Objectives: Part A (dose ranging study): To demonstrate that sari...
Status
Completed
Location
Investigational Site Number 840070
Start Date
2010-03
Trial ID
NCT01061736
Treatments Being Tested
Primary Objective: To describe the pharmacokinetic (PK) profile of sarilum...
Status
Recruiting
Location
Investigational Site Number : 0320004
Start Date
2018-08-09
Trial ID
NCT02991469
Treatments Being Tested
Primary Objective: To evaluate the efficacy of KEVZARA (sarilumab) in part...
Status
Terminated
Location
Investigational Site Number 8400003
Start Date
2018-10-09
Trial ID
NCT03600818